201 related articles for article (PubMed ID: 33820830)
1. Ginsenoside Ro Ameliorates High-Fat Diet-Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein-Coupled Bile Acid Receptor 5 Pathway.
Jiang LS; Li W; Zhuang TX; Yu JJ; Sun S; Ju ZC; Wang ZT; Ding LL; Yang L
J Pharmacol Exp Ther; 2021 Jun; 377(3):441-451. PubMed ID: 33820830
[TBL] [Abstract][Full Text] [Related]
2. Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway.
Li W; Zhuang T; Wang Z; Wang X; Liu L; Luo Y; Wang R; Li L; Huang W; Wang Z; Yang L; Ding L
Phytomedicine; 2023 Oct; 119():154982. PubMed ID: 37531904
[TBL] [Abstract][Full Text] [Related]
3. Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice.
Ding L; Yang Q; Zhang E; Wang Y; Sun S; Yang Y; Tian T; Ju Z; Jiang L; Wang X; Wang Z; Huang W; Yang L
Acta Pharm Sin B; 2021 Jun; 11(6):1541-1554. PubMed ID: 34221867
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
5. TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice.
McGavigan AK; Garibay D; Henseler ZM; Chen J; Bettaieb A; Haj FG; Ley RE; Chouinard ML; Cummings BP
Gut; 2017 Feb; 66(2):226-234. PubMed ID: 26511794
[TBL] [Abstract][Full Text] [Related]
6. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
[TBL] [Abstract][Full Text] [Related]
7. Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass.
Zhai H; Li Z; Peng M; Huang Z; Qin T; Chen L; Li H; Zhang H; Zhang W; Xu G
EBioMedicine; 2018 Jun; 32():201-214. PubMed ID: 29859856
[TBL] [Abstract][Full Text] [Related]
8. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR
Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014
[TBL] [Abstract][Full Text] [Related]
9. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
Huang S; Ma S; Ning M; Yang W; Ye Y; Zhang L; Shen J; Leng Y
Metabolism; 2019 Oct; 99():45-56. PubMed ID: 31295453
[TBL] [Abstract][Full Text] [Related]
10. [Effect of ginsenoside Rb1 in ameliorating insulin resistance and ectopic fat deposition in obese mice induced by high fat diet].
Shang WB; Yu XZ; Wang GQ; Zhao J
Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4119-23. PubMed ID: 24791501
[TBL] [Abstract][Full Text] [Related]
11. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.
Potthoff MJ; Potts A; He T; Duarte JA; Taussig R; Mangelsdorf DJ; Kliewer SA; Burgess SC
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G371-80. PubMed ID: 23257920
[TBL] [Abstract][Full Text] [Related]
12. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
[TBL] [Abstract][Full Text] [Related]
13. Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice.
He M; Su H; Gao W; Johansson SM; Liu Q; Wu X; Liao J; Young AA; Bartfai T; Wang MW
PLoS One; 2010 Dec; 5(12):e14205. PubMed ID: 21151924
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of the bile acid receptor TGR5 in metabolism.
van Nierop FS; Scheltema MJ; Eggink HM; Pols TW; Sonne DP; Knop FK; Soeters MR
Lancet Diabetes Endocrinol; 2017 Mar; 5(3):224-233. PubMed ID: 27639537
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis.
Kim H; Fang S
Lab Anim Res; 2018 Dec; 34(4):140-146. PubMed ID: 30671099
[TBL] [Abstract][Full Text] [Related]
16. Bile acid receptor TGR5 is critically involved in preference for dietary lipids and obesity.
Bensalem A; Murtaza B; Hichami A; Khan AS; Oulamara H; Merlen G; Berrichi M; Agli AN; Tordjmann T; Khan NA
J Nutr Biochem; 2020 Feb; 76():108298. PubMed ID: 31812910
[TBL] [Abstract][Full Text] [Related]
17. TGR5-mediated bile acid sensing controls glucose homeostasis.
Thomas C; Gioiello A; Noriega L; Strehle A; Oury J; Rizzo G; Macchiarulo A; Yamamoto H; Mataki C; Pruzanski M; Pellicciari R; Auwerx J; Schoonjans K
Cell Metab; 2009 Sep; 10(3):167-77. PubMed ID: 19723493
[TBL] [Abstract][Full Text] [Related]
18. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.
Jadhav K; Xu Y; Xu Y; Li Y; Xu J; Zhu Y; Adorini L; Lee YK; Kasumov T; Yin L; Zhang Y
Mol Metab; 2018 Mar; 9():131-140. PubMed ID: 29361497
[TBL] [Abstract][Full Text] [Related]
19. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
Donepudi AC; Boehme S; Li F; Chiang JY
Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
[TBL] [Abstract][Full Text] [Related]
20. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
